In his keynote lecture Richard Cattell, Deputy Chief Pharmaceutical Officer, asked pharmacists to do three things: Make their voices heard in the development of the NHS 10-year plan… read more.
A pharmacy professor at Binghamton University, State University of New York has a $1.9 million grant from the National Institute of General Medical Sciences to tackle gene therapy challengs…. read more.
FIP’s Early Career in Pharmaceutical Practice Recognition Award recognises an outstanding early career pharmacist who has made significant contributions to the field at a national level and is… read more.
Ensuring older hospital patients receive specialised medication management could reduce their stay in hospital and potentially lower their risk of death, according to new research conducted by Flinders… read more.
Steve Tomlin is a pharmacist and Director of the Children’s Medicines Research and Innovation Centre (CMRIC) at Great Ormond Street Hospital for Children in London. His mission is… read more.
Researchers at The University of Texas at El Paso are developing a new therapeutic approach that uses nanoparticles for the treatment of skin and lung fibrosis, conditions that… read more.
As Director of the Children’s Medicines Research and Innovation Centre (CMRIC) at Great Ormond Street Hospital for Children in London, Steve Tomlin now uses his experience of hands-on… read more.
Effective use of standardised products in neonatology depends on expert knowledge of both the clinical situation and the pharmaceutics of the products – and this is where prescribing… read more.
A parenteral nutrition solution contains about 50 different components and is critical for survival and growth of a pre-term infant. Managing such products requires a good understanding of… read more.
Steve Tomlin is a pharmacist and Director of the Children’s Medicines Research and Innovation Centre (CMRIC) at Great Ormond Street Hospital for Children in London. His mission is… read more.
Whether it’s costs, safety risks or “pill fatigue” they’re trying to reduce, many health systems and clinics have started working on ways to encourage deprescribing of medications that… read more.
Much has been written about deprescribing of medicines with anticholinergic effects to reduce overall anticholinergic burden and it is widely recommended as a way to reduce cognitive impairment,… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
